US objection on Brazil's first time request in “Cotton” case
06 Sep '06
2 min read
The fee structure had been changed and certain markets which had been designated as eligible markets had been eliminated.
According to the US, these changes responded to key DSB findings about charging premiums that were “risk-based” and designed to cover long-term operating costs and losses of such programmes. The US stated that, in the face of these implementing measures, Brazil's complaint had no factual or legal basis.
The US further stated that Brazil's request was defective, as the sequencing agreement (WT/DS267/22)reached between the parties only covered some of its claims.
The US concluded by saying that a proposal by the US for an additional sequencing agreement had been refused by Brazil making it difficult for the US to accept the establishment of a compliance panel at the present meeting.
marketing@alchempro.com
